Dr. Barry Dworkin

Moderna reports on successful development of variant-specific updates to its vaccine.

Medical Mythbusting Commentary for April 20, 2022

Source:
Moderna says new booster plus original shot provides better COVID-19 protection

Related posts:

  1. CDC and other regulators working to assess risk and if there is a causal relationship between mRNA vaccines and myo/pericarditis seen predominately in a small number of males 16-24 years old after 2nd dose.
  2. Retracted Canadian study that reported 1/1000 risk of myocarditis from mRNA vaccine weaponized by anti-vaccination websites despite data correction by the authors to 1/25,000. Review system worked to uncover error but damage now done.
  3. Moderna CEO should quell their speculative and alarmist comments about Omicron. In times of uncertainty, statements should be calm, measured, humble, and neutral in tone. Answers likely forthcoming in 1-2 wks. Solutions will follow thereafter.
  4. Moderna Says Its New COVID-19 Vaccine Protects Against the BA.2.86 Variant